Stay updated on Dupilumab in Pediatric Peanut Allergy Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Pediatric Peanut Allergy Clinical Trial page.

Latest updates to the Dupilumab in Pediatric Peanut Allergy Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the page.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded revision: v3.4.2; removed the funding-status notice and the prior revision: v3.4.1.SummaryDifference0.4%

- Check38 days agoChange DetectedA site-wide notice about government funding status and a version update (v3.4.1) were added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check45 days agoChange DetectedMinor UI/text updates: a 'Show glossary' option is displayed, the QC-related label is updated (Last Update Submitted that Met QC Criteria), and the revision is updated to v3.4.0 with capitalization tweaks for 'No FEAR Act Data'.SummaryDifference0.2%

- Check59 days agoChange DetectedA minor site revision update was made, adding Revision: v3.3.4 and removing Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedA new dedicated Locations section has been added with regional site listings (California, Florida, Indiana, Michigan, New York, Ontario, Quebec), and the previous location groupings have been removed.SummaryDifference0.8%

Stay in the know with updates to Dupilumab in Pediatric Peanut Allergy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Pediatric Peanut Allergy Clinical Trial page.